ACTL6A and head and neck squamous cell carcinoma: Furthermore, elevated levels of ACTL6A expression are a negative prognostic factor of HNSCC patient survival, suggesting that ACTL6A has an oncogenic function in HNSCC (Saladi et al., 2017).